dichlororibofuranosylbenzimidazole has been researched along with oligonucleotides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pfleiderer, W; Ruf, K | 1 |
| Harlow, P; Molloy, GR | 1 |
| Luecke, HF; Yamamoto, KR | 1 |
3 other study(ies) available for dichlororibofuranosylbenzimidazole and oligonucleotides
| Article | Year |
|---|---|
Synthesis and properties of 5,6-dichlorobenzimidazole 2'----5'- and 3'----5'-nucleotide dimers and trimers.
Topics: Antiviral Agents; Dichlororibofuranosylbenzimidazole; Magnetic Resonance Spectroscopy; Molecular Structure; Oligonucleotides | 1991 |
Isolation of oligo(U)-containing heterogeneous nuclear RNA from control and 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-treated HeLa cells.
Topics: Base Sequence; Cell Nucleus; Chromatography, Agarose; Dichlororibofuranosylbenzimidazole; Formaldehyde; HeLa Cells; Humans; Nucleic Acid Denaturation; Oligonucleotides; Oligoribonucleotides; Ribonucleosides; RNA; Sepharose; Uracil Nucleotides | 1981 |
The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression.
Topics: Chromatin Immunoprecipitation; Dichlororibofuranosylbenzimidazole; Gene Expression Regulation; Glutathione Transferase; Humans; I-kappa B Proteins; Interleukin-8; Models, Biological; NF-kappa B; NF-KappaB Inhibitor alpha; Oligonucleotides; Phosphorylation; Positive Transcriptional Elongation Factor B; Promoter Regions, Genetic; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA Polymerase II; RNA, Small Interfering; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2005 |